30
Participants
Start Date
September 28, 2017
Primary Completion Date
March 17, 2020
Study Completion Date
June 25, 2020
Afrezza
"Pharmaceutical form: powder~Route of administration: inhalation"
Children's Hospital of Philadelphia, Philadelphia
Barry J. Reiner, MD, LLC, Baltimore
Atlanta Diabetes Associates, Atlanta
Van Meter Pediatric Endocrinology, P.C., Atlanta
Emory University Children's Center, Atlanta
University of Florida, Gainesville
USF Diabetes Center, Tampa
Le Bonheur Children's Hospital, Memphis
Indiana University, Riley Hospital for Children, Indianapolis
Barbara Davis Center for Childhood Diabetes, Aurora
Diabetes, Obesity, Cardiovascular Clinical Specialists (DOCS), Las Vegas
Children's Hospital Los Angeles, Los Angeles
Yale University Hospital, New Haven
Lead Sponsor
Mannkind Corporation
INDUSTRY